SCHEMBL7995924

SCHEMBL7995924

CC(C)(C)OC(=O)C1CC=NO1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29712270 0.79 — —
SCHEMBL7870784 0.70 MAPK1 (0.38) MAPK1
SCHEMBL7870788 0.70 MAPK1 (0.38) MAPK1
SCHEMBL16586932 0.69 MAPK1 (0.36) MAPK1
SCHEMBL21125959 0.69 MAPK1 (0.37) MAPK1
SCHEMBL25061491 0.68 MIF (0.35) MAPK1
SCHEMBL19899949 0.68 MIF (0.38) MAPK1
SCHEMBL29913677 0.67 PKM (0.40) —
SCHEMBL2535414 0.66 MAPK1 (0.42) MAPK1
SCHEMBL29068359 0.66 MAPK1 (0.33) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110709081-B Compounds and methods for treating bacterial infections 恩塔西斯治疗公司 2023-09-22 — — CN disclosed
WO-2000033836-A9 5-MEMBERED HETEROCYCLES FOR THE TREATMENT OF HUMAN DISEASES INVOLVING MODULATORS OF SELECTINS ONTOGEN CORP (US) 2001-10-04 — — WO disclosed
WO-2000033836-A1 5-MEMBERED HETEROCYCLES FOR THE TREATMENT OF HUMAN DISEASES INVOLVING MODULATORS OF SELECTINS ONTOGEN CORPORATION (US) 2000-06-15 — — WO disclosed
Send feedback